Breakthrough Therapy for Complex Crohn’s Disease Enters Clinical Trials

A promising new treatment for complex fistulising perianal Crohn’s disease, one of the most debilitating and treatment-resistant forms of inflammatory bowel disease (IBD), is entering its first clinical trial. This condition, which affects one-third of Crohn’s patients, causes severe infections, chronic inflammation, and debilitating complications with few effective treatment options.

Extracellular Vesicles (EVs) Instead of Stem Cells